Edition:
United States

Argos Therapeutics Inc (ARGS.OQ)

ARGS.OQ on NASDAQ Stock Exchange Capital Market

0.32USD
3:02pm EDT
Change (% chg)

$-0.01 (-3.03%)
Prev Close
$0.33
Open
$0.34
Day's High
$0.36
Day's Low
$0.27
Volume
709,988
Avg. Vol
140,110
52-wk High
$11.95
52-wk Low
$0.27

Select another date:

Mon, Apr 2 2018

BRIEF-Argos Therapeutics Reports Q4 Loss Per Share $0.38

* ARGOS THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

REFILE-BRIEF-Argos Therapeutics' Cash And Cash Equivalents About $15.2 Mln At Year End

* ARGOS THERAPEUTICS INC SAYS ESTIMATES THAT ITS CASH AND CASH EQUIVALENTS AS OF DEC 31, 2017 WERE ABOUT $15.2 MILLION

BRIEF-Argos Obtains Option To License PD1 Checkpoint Inhibitors

* ARGOS THERAPEUTICS INC - ENTERED INTO AN OPTION AGREEMENT WITH PHARMSTANDARD INTERNATIONAL, S.A. AND ACTIGEN LIMITED

BRIEF-Argos Therapeutics Board Approves One-For-Twenty Reverse Split Of Co's Common Stock Effective Jan 18, After Close

* ARGOS THERAPEUTICS - BOARD APPROVED ONE-FOR-TWENTY REVERSE SPLIT OF CO'S COMMON STOCK THAT WILL TAKE EFFECT JANUARY 18, AFTER CLOSE OF TRADING Source text for Eikon: Further company coverage:

BRIEF-Argos Announces $1.5 Million Equity Investment By Lummy (Hong Kong) Ltd

* ARGOS ANNOUNCES $1.5 MILLION EQUITY INVESTMENT BY LUMMY (HONG KONG), LTD. Source text for Eikon: Further company coverage:

BRIEF-Argos Therapeutics Enters Into Agreement With Saint-Gobain Performance Plastics Corp

* ARGOS THERAPEUTICS - ‍ON NOV 22, ENTERED INTO A SATISFACTION AND RELEASE AGREEMENT WITH SAINT-GOBAIN PERFORMANCE PLASTICS CORP - SEC FILING

BRIEF-Argos Provides Financial Update

* ARGOS THERAPEUTICS - ‍TKC PROPERTIES HAS, WITH ARGOS' FULL CONSENT, SUCCESSFULLY COMPLETED SALE OF FACILITY IN DURHAM COUNTY, NC TO A THIRD PARTY​

BRIEF-Argos reports third quarter financial results

* Argos reports third quarter 2017 financial results and operational highlights

BRIEF-Argos Therapeutics files for offering of 13.5 mln shares of common stock by Invetech

* Argos Therapeutics files for offering of 13.5 million shares of common stock by Invetech Pty Ltd - SEC filing Source text: (http://bit.ly/2zcHDkV) Further company coverage:

Select another date: